SOMERSET, N.J., May 6, 2008 (PRIME NEWSWIRE) -- inVentiv Health, Inc. (Nasdaq:VTIV) today announced that it will present at three upcoming investor conferences.
David Bassin, Chief Financial Officer, will make a presentation at the Bank of America 2008 Health Care Conference in Las Vegas. inVentiv's presentation will be on May 14 at 4 p.m. PDT in The Four Seasons Hotel in Las Vegas.
Mr. Bassin and Eran Broshy, Chief Executive Officer, will present at the 2008 Citi Investment Research Global Health Care Conference in New York. The presentation will take place at the Hilton New York on May 22 at 11 a.m. EDT.
Mr. Bassin and Mr. Broshy also will present at the FBR Capital Markets 12th Annual Spring Investor Conference in New York. The presentation will be on May 29 at 12:50 p.m. EDT at the Grand Hyatt New York.
An audio webcast of these presentations will be available by logging on to www.inventivhealth.com/health/newsroom/webcasts.asp.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq:VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 325 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.
The inVentiv Health, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4942
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.